Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 36

Sort by

Sort Order Select

Journal Articles

Association between elevated white blood cell counts and thrombotic events in polycythemia vera: analysis from REVEAL

Aaron T. Gerds, Ruben Mesa, John M. Burke, Michael R. Grunwald, Brady L. Stein, Peg Squier, Jingbo Yu, J. E. Hamer-Maansson, Stephen T. Oh

Blood (2024) 143 (16): 1646–1655.

https://doi.org/10.1182/blood.2023020232

Published: 2024

Includes: Supplemental data

Journal Articles

Multicenter Retrospective Analysis of Eosinophilic Myeloid Neoplasms

Blood (2023) 142 (Supplement 1): 4576.

https://doi.org/10.1182/blood-2023-187092

Published: 2023

Journal Articles

Clinical Practice Gaps in Managing Patients with Myelofibrosis: Comparison of Healthcare Professional and Expert Treatment Choices Provided to an Online Decision Support Tool

Ryan P. Topping, Prithviraj Bose, John Mascarenhas, Raajit K. Rampal, Brady L. Stein, Timothy A. Quill, Ruben A. Mesa

Blood (2023) 142 (Supplement 1): 7291.

https://doi.org/10.1182/blood-2023-174268

Published: 2023

Journal Articles

Developing a Cancer-Associated Thrombosis Clinic: Two-Year Experience

Brandon Bungo, Lindsey Kalhagen, Caroline Laub, Iwona Boska, Anaadriana Zakarija, Brady L. Stein, Karlyn A. Martin

Blood (2022) 140 (Supplement 1): 5005–5006.

https://doi.org/10.1182/blood-2022-166508

Published: 2022

Journal Articles

Improving Hematology Clinic Access for Patients with Cancer-Associated Thrombosis

Karlyn A. Martin, Caroline Laub, Lindsey Kalhagen, Iwona Boska, Mark Attilio, Anaadriana Zakarija, Brady L. Stein

Blood (2021) 138 (Supplement 1): 1885.

https://doi.org/10.1182/blood-2021-151152

Published: 2021

Journal Articles

Loss of LKB1/ STK11 Facilitates Leukemic Progression of the Myeloproliferative Neoplasms

Christian Marinaccio, MSc, Praveen K Suraneni, PhD, Hamza Celik, PhD, Andrew Volk, PhD, Jeremy Q. Wen, MD PhD, Te Ling, PhD, Terra Lasho, PhD, Richard P. Koche, PhD, Christopher Famulare, MS, Brady L. Stein, MD, Sandeep Gurbuxani, MBBS, PhD, Ronald Hoffman, MD, Naseema Gangat, MBBS, Navdeep Chandel, Ross L. Levine, MD, Raajit K. Rampal, MD PhD, Grant Challen, Ayalew Tefferi, MD, John D. Crispino, PhD

Blood (2020) 136 (Supplement 1): 1.

https://doi.org/10.1182/blood-2020-140557

Published: 2020

Journal Articles

To Treat or Not to Treat? Understanding Treatment Patterns in Patients with Lower-Risk Myelofibrosis at the Time of Enrollment in the MOST Study

Rami S. Komrokji, MD, Brady L. Stein, MD MHSc, Robyn M. Scherber, MD, Patricia Kalafut, PhD, Haobo Ren, PhD, Srdan Verstovsek, MD PhD

Blood (2020) 136 (Supplement 1): 49–51.

https://doi.org/10.1182/blood-2020-134958

Published: 2020

Journal Articles

Mortality and Causes of Death of Patients with Polycythemia Vera: Analysis of the Reveal Prospective, Observational Study

Brady L. Stein, MD MHSc, Kamal Patel, MD, Robyn M. Scherber, MD, Jingbo Yu, MD PhD, Dilan Paranagama, PhD, Carole B. Miller, MD

Blood (2020) 136 (Supplement 1): 36–37.

https://doi.org/10.1182/blood-2020-137144

Published: 2020

Journal Articles

From Budd-Chiari syndrome to acquired von Willebrand syndrome: thrombosis and bleeding complications in the myeloproliferative neoplasms

Brady L. Stein, Karlyn Martin

Blood (2019) 134 (22): 1902–1911.

https://doi.org/10.1182/blood.2019001318

Published: 2019

Journal Articles

Long-Term Antithrombotic Therapy after Venous Stent Placement

Chenyu Lin, MD, Karlyn A. Martin, MD, Mei Wang, PhD, Brady L. Stein, MD, Kush R. Desai, MD

Blood (2018) 132 (Supplement 1): 1249.

https://doi.org/10.1182/blood-2018-99-111069

Published: 2018

Journal Articles

Temporary and Permanent Inferior Vena Cava Filters in the Oncology Population

Suneel Deepak Kamath, MD, Elizabeth H. Cull, MD, Brady L. Stein, MD, Robert Lewandowski, MD, Brandon McMahon, MD

Blood (2016) 128 (22): 1423.

https://doi.org/10.1182/blood.V128.22.1423.1423

Published: 2016

Journal Articles

Examining the Clinical Features and Underlying Cardiovascular Risk Among Patients with Polycythemia Vera in the REVEAL Study

Brady L. Stein, MD, Ahmad Naim, MD, Michael R. Grunwald, MD, Alison R. Moliterno, MD, Stephen T. Oh, MD PhD, Dilan Paranagama, PhD, Joseph A. Cordaro, PharmD, MBA, Hao Sun, MS, Shreekant Parasuraman, BPharm, PhD, Ralph V. Boccia, Ruben Mesa, MD FACP

Blood (2016) 128 (22): 1934.

https://doi.org/10.1182/blood.V128.22.1934.1934

Published: 2016

Journal Articles

Diagnosis and Management of Polycythemia Vera in the Post- JAK2 V617F Discovery Era: A Survey of Practice Patterns

Brady L Stein, MDMHS, Elizabeth M Kander, MD, Zheng Zhou, MD PhD, Michael B. Streiff, MD, Alison R Moliterno, MD, Jerry L. Spivak, MD

Blood (2014) 124 (21): 2172.

https://doi.org/10.1182/blood.V124.21.2172.2172

Published: 2014

Journal Articles

Defect in Ribosome Biogenesis Contributes to Impaired Megakaryopoiesis in Primary Myelofibrosis

Laure Gilles, PhD, Ahmet Dirim Arslan, PhD, Katerina Konstantinoff, Maureen McNulty, Lasho Terra, PhD, Animesh Pardanani, MBBS, PhD, Brady L Stein, MD, Isabelle Plo, William Vainchenker, MD PhD, Leonidas Platanias, Ayalew Tefferi, MD, John D Crispino, PhD

Blood (2014) 124 (21): 4585.

https://doi.org/10.1182/blood.V124.21.4585.4585

Published: 2014

Journal Articles

Essential Thrombocytosis: Redefinition in the Genomic Era

Donna M. Williams, PhD, Michael A McDevitt, MD PhD, Brady L Stein, MDMHS, Ophelia Rogers, Michael B. Streiff, MD, David Neal, Sophie Lanzkron, MD MHS, Linda M. S. Resar, MD, Christine O'Keefe, PhD, Jaroslaw P. Maciejewski, MD PhD, Jerry L. Spivak, MD, Alison R. Moliterno, MD

Blood (2014) 124 (21): 3205.

https://doi.org/10.1182/blood.V124.21.3205.3205

Published: 2014

Journal Articles

Prevalence,Type, and Risk Factors for Bleeding in a Large Cohort of Myeloproliferative Neoplasm Patients

Elizabeth M Kander, MD, Sania S. Raza, MD, Zheng Zhou, MD PhD, David Dittmann, Juehua Gao, MD, PhD, Brandon McMahon, MD, Brady L Stein, MDMHS

Blood (2014) 124 (21): 3207.

https://doi.org/10.1182/blood.V124.21.3207.3207

Published: 2014

Journal Articles

Temporary Vena Cava Filters in Oncology Patients

Elizabeth H Cull, MD, Robert Lewandowski, MD, Brady L Stein, MD, Brandon McMahon, MD

Blood (2014) 124 (21): 4247.

https://doi.org/10.1182/blood.V124.21.4247.4247

Published: 2014

Journal Articles

Burden of Disease and Clinical Responses in Low and Intermediate-1 Risk Myelofibrosis Patients Treated with Ruxolitinib

Ahmad Zarzour, MD, Ali Tabarroki, MD, Valeria Visconte, PhD, Rokana Taftaf, MD, Heesun J. Rogers, MD PhD, Jing Ai, MD PhD, Nikolaos Papadantonakis, MD PhD, Alan E. Lichtin, Yogen Saunthararajah, MD, Brady L Stein, MDMHS, Ramon V. Tiu, MD

Blood (2014) 124 (21): 1834.

https://doi.org/10.1182/blood.V124.21.1834.1834

Published: 2014

Journal Articles

A Phase 1/2, Open-Label, Dose-Escalation, Multi-Center Study to Assess the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Orally Administered NS-018 in Patients with Primary Myelofibrosis (PMF), Post-Polycythemia Vera Myelofibrosis (postPV MF), or Post-Essential Thrombocythemia Myelofibrosis (postET MF)

Srdan Verstovsek, MD PhD, Moshe Talpaz, MD, Ellen K. Ritchie, MD, Martha Wadleigh, MD, Olatoyosi Odenike, MD, Catriona Jamieson, MD PhD, Brady L Stein, MD, Uno Tomonori, PhD, Ruben Mesa, MD

Blood (2014) 124 (21): 1839.

https://doi.org/10.1182/blood.V124.21.1839.1839

Published: 2014

Journal Articles

Clinical Use Of Anti-Xa Monitoring In Malignancy-Associated Thrombosis

Brandon McMahon, MD, Sarah Yentz, MD, Oluwatoyosi A. Onwuemene, MD, Brady L. Stein, MD, Elizabeth H. Cull, MD

Blood (2013) 122 (21): 3648.

https://doi.org/10.1182/blood.V122.21.3648.3648

Published: 2013

NARROW

Association between elevated white blood cell counts and thrombotic events in polycythemia vera: analysis from REVEAL

Multicenter Retrospective Analysis of Eosinophilic Myeloid Neoplasms

Clinical Practice Gaps in Managing Patients with Myelofibrosis: Comparison of Healthcare Professional and Expert Treatment Choices Provided to an Online Decision Support Tool

Developing a Cancer-Associated Thrombosis Clinic: Two-Year Experience

Improving Hematology Clinic Access for Patients with Cancer-Associated Thrombosis

Loss of LKB1/ STK11 Facilitates Leukemic Progression of the Myeloproliferative Neoplasms

To Treat or Not to Treat? Understanding Treatment Patterns in Patients with Lower-Risk Myelofibrosis at the Time of Enrollment in the MOST Study

Mortality and Causes of Death of Patients with Polycythemia Vera: Analysis of the Reveal Prospective, Observational Study

From Budd-Chiari syndrome to acquired von Willebrand syndrome: thrombosis and bleeding complications in the myeloproliferative neoplasms

Long-Term Antithrombotic Therapy after Venous Stent Placement

Temporary and Permanent Inferior Vena Cava Filters in the Oncology Population

Examining the Clinical Features and Underlying Cardiovascular Risk Among Patients with Polycythemia Vera in the REVEAL Study

Diagnosis and Management of Polycythemia Vera in the Post- JAK2 V617F Discovery Era: A Survey of Practice Patterns

Defect in Ribosome Biogenesis Contributes to Impaired Megakaryopoiesis in Primary Myelofibrosis

Essential Thrombocytosis: Redefinition in the Genomic Era

Prevalence,Type, and Risk Factors for Bleeding in a Large Cohort of Myeloproliferative Neoplasm Patients

Temporary Vena Cava Filters in Oncology Patients

Burden of Disease and Clinical Responses in Low and Intermediate-1 Risk Myelofibrosis Patients Treated with Ruxolitinib

Clinical Use Of Anti-Xa Monitoring In Malignancy-Associated Thrombosis

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only